NOVA (ENGOT-OV16): Niraparib Maintenance in Recurrent Ovarian Cancer Last updated on Jun 5, 2026 Previous ICON7: Bevacizumab Added to Front-Line Chemotherapy for Ovarian Cancer Next VELIA: Veliparib with First-Line Chemotherapy and Maintenance in Ovarian Cancer
